254 related articles for article (PubMed ID: 11297434)
21. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.
Francis GA; Knopp RH; Oram JF
J Clin Invest; 1995 Jul; 96(1):78-87. PubMed ID: 7615839
[TBL] [Abstract][Full Text] [Related]
22. Oxidative tyrosylation of HDL enhances the depletion of cellular cholesteryl esters by a mechanism independent of passive sterol desorption.
Francis GA; Oram JF; Heinecke JW; Bierman EL
Biochemistry; 1996 Dec; 35(48):15188-97. PubMed ID: 8952466
[TBL] [Abstract][Full Text] [Related]
23. ABCA1 and nascent HDL biogenesis.
Wang S; Smith JD
Biofactors; 2014; 40(6):547-54. PubMed ID: 25359426
[TBL] [Abstract][Full Text] [Related]
24. Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity.
Murphy AJ; Funt S; Gorman D; Tall AR; Wang N
Circ Res; 2013 Jun; 113(1):e1-e9. PubMed ID: 23613182
[TBL] [Abstract][Full Text] [Related]
25. Limited proteolysis of high density lipoprotein abolishes its interaction with cell-surface binding sites that promote cholesterol efflux.
Mendez AJ; Oram JF
Biochim Biophys Acta; 1997 Jun; 1346(3):285-99. PubMed ID: 9219913
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the structural and functional effects of monomeric and dimeric human apolipoprotein A-II in high density lipoprotein particles.
Lund-Katz S; Murley YM; Yon E; Gillotte KL; Davidson WS
Lipids; 1996 Nov; 31(11):1107-13. PubMed ID: 8934442
[TBL] [Abstract][Full Text] [Related]
27. Effect of reconstituted discoidal high-density lipoproteins on lipid mobilization in RAW 264.7 and CHOK1 cells.
Toledo JD; Cabaleiro LV; Garda HA; Gonzalez MC
J Cell Biochem; 2012 Apr; 113(4):1208-16. PubMed ID: 22095661
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein A-I structural modification and the functionality of reconstituted high density lipoprotein particles in cellular cholesterol efflux.
Gillotte KL; Davidson WS; Lund-Katz S; Rothblat GH; Phillips MC
J Biol Chem; 1996 Sep; 271(39):23792-8. PubMed ID: 8798607
[TBL] [Abstract][Full Text] [Related]
29. Function of different proportions of apolipoprotein A-I cysteine mutants and apolipoprotein A-V on recombinant high-density lipoproteins
Yan Y; Lu S; Jia S; Dong Q; Wang L; Wang Y
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31023964
[TBL] [Abstract][Full Text] [Related]
30. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR
J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656
[TBL] [Abstract][Full Text] [Related]
31. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport.
Castro G; Nihoul LP; Dengremont C; de Geitère C; Delfly B; Tailleux A; Fievet C; Duverger N; Denèfle P; Fruchart JC; Rubin EM
Biochemistry; 1997 Feb; 36(8):2243-9. PubMed ID: 9047326
[TBL] [Abstract][Full Text] [Related]
32. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux.
Remaley AT; Schumacher UK; Stonik JA; Farsi BD; Nazih H; Brewer HB
Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1813-21. PubMed ID: 9327782
[TBL] [Abstract][Full Text] [Related]
33. The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein.
Davidson WS; Lund-Katz S; Johnson WJ; Anantharamaiah GM; Palgunachari MN; Segrest JP; Rothblat GH; Phillips MC
J Biol Chem; 1994 Sep; 269(37):22975-82. PubMed ID: 8083197
[TBL] [Abstract][Full Text] [Related]
34. Recombinant high density lipoprotein reconstituted with apolipoprotein AI cysteine mutants as delivery vehicles for 10-hydroxycamptothecin.
Zhang X; Chen B
Cancer Lett; 2010 Dec; 298(1):26-33. PubMed ID: 20579804
[TBL] [Abstract][Full Text] [Related]
35. Evidence that apolipoprotein A-I facilitates hepatic lipase-mediated phospholipid hydrolysis in reconstituted HDL containing apolipoprotein A-II.
Hime NJ; Barter PJ; Rye KA
Biochemistry; 2001 May; 40(18):5496-505. PubMed ID: 11331014
[TBL] [Abstract][Full Text] [Related]
36. Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1.
Favari E; Calabresi L; Adorni MP; Jessup W; Simonelli S; Franceschini G; Bernini F
Biochemistry; 2009 Nov; 48(46):11067-74. PubMed ID: 19839639
[TBL] [Abstract][Full Text] [Related]
37. Administration of tyrosyl radical-oxidized HDL inhibits the development of atherosclerosis in apolipoprotein E-deficient mice.
Macdonald DL; Terry TL; Agellon LB; Nation PN; Francis GA
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1583-8. PubMed ID: 12855483
[TBL] [Abstract][Full Text] [Related]
38. Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells.
Baker PW; Rye KA; Gamble JR; Vadas MA; Barter PJ
J Lipid Res; 1999 Feb; 40(2):345-53. PubMed ID: 9925665
[TBL] [Abstract][Full Text] [Related]
39. Tweaking the cholesterol efflux capacity of reconstituted HDL.
Ma CI; Beckstead JA; Thompson A; Hafiane A; Wang RH; Ryan RO; Kiss RS
Biochem Cell Biol; 2012 Oct; 90(5):636-45. PubMed ID: 22607224
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation.
Rye KA; Wee K; Curtiss LK; Bonnet DJ; Barter PJ
J Biol Chem; 2003 Jun; 278(25):22530-6. PubMed ID: 12690114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
